Aug 02, 2018
Regeneron Reports Second Quarter 2018 Financial and Operating Results
Jul 31, 2018
Q2 2018 Performance Positions Sanofi for New Growth Phase
Jul 09, 2018
Regeneron to Report Second Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on August 2, 2018
Jun 04, 2018
New England Journal of Medicine Publishes Pivotal Cemiplimab Trials Showing Positive Results in Advanced Cutaneous Squamous Cell Carcinoma
May 31, 2018
Regeneron's Investigational Ebola Treatment Shipping to Democratic Republic of the Congo for Use in Current Outbreak
May 18, 2018
Regeneron Announces Upcoming Investor Conference Presentation
May 16, 2018
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO
May 03, 2018
Sanofi/Regeneron's Dupixent, the Darling of Atopic Dermatitis
May 03, 2018
Regeneron Reports First Quarter 2018 Financial and Operating Results
May 01, 2018
Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients
May 01, 2018
Regeneron and Sanofi to Lower Net Price of Praluent® (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Apr 30, 2018
FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Apr 27, 2018
Sanofi: First-quarter 2018 Business EPS up 1.4% at CER
Apr 23, 2018
Regeneron Announces Upcoming Investor Conference Presentations
Apr 12, 2018
Free Research Reports on These Biotech Stocks -- Regeneron Pharma, Sangamo Therapeutics, Seattle Genetics, and Spectrum Pharma
Apr 09, 2018
Regeneron to Report First Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2018
Apr 03, 2018
EMA to Review Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Mar 21, 2018
Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH)
Mar 21, 2018
Regeneron Genetics Center® Publication in New England Journal of Medicine Identifies New Genetic Variant Providing Protection from Chronic Liver Disease
Mar 19, 2018
EYLEA® (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial